Real-world evaluation of effectiveness and tolerance of chemotherapy for early-stage breast cancer in older women Glenda M. Delgado-RamosSyed Sameer NasirLee S. Schwartzberg Review 23 May 2020 Pages: 247 - 258
Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer Daniel ReinhornRinat YerushalmiHadar Goldvaser Review 01 June 2020 Pages: 259 - 266
Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival Chitra JosephMansour AlsaleemEmad A. Rakha Preclinical study Open access 22 May 2020 Pages: 267 - 282
Diffusion-weighted MRI at 3.0 T for detection of occult disease in the contralateral breast in women with newly diagnosed breast cancer Su Min HaJung Min ChangWoo Kyung Moon Clinical trial 23 May 2020 Pages: 283 - 297
A comparison of two non-radioactive alternatives to wire for the localization of non-palpable breast cancers Minna K. LeeYas SanaihaMaggie L. DiNome Clinical trial 25 May 2020 Pages: 299 - 303
Sensory profiles in women with neuropathic pain after breast cancer surgery L. MustonenJ. VollertH. Harno Clinical trial Open access 27 May 2020 Pages: 305 - 315
Intracystic papillary carcinoma: clinical presentation, patterns of practice, and oncological outcomes Zeina HassanFouad BoulosEman Sbaity Clinical trial 28 May 2020 Pages: 317 - 323
NSAS-BC02 substudy of chemotherapy-induced amenorrhea (CIA) in premenopausal patients who received either taxane alone or doxorubicin(A) cyclophosphamide(C) followed by taxane as postoperative chemotherapy Takayuki IwamotoFumikata HaraYasuo Ohashi Clinical Trial 28 May 2020 Pages: 325 - 332
Cumulative incidence of chemotherapy-induced cardiotoxicity during a 2-year follow-up period in breast cancer patients Hyunsoon ChoSanghee LeeHak Jin Kim Clinical trial 28 May 2020 Pages: 333 - 343
Predictive risk factors of complications in different breast reconstruction methods J. S. PalveT. H. LuukkaalaM. T. Kääriäinen Clinical trial Open access 28 May 2020 Pages: 345 - 354
Cost-effectiveness analysis of endocrine therapy alone versus partial-breast irradiation alone versus combined treatment for low-risk hormone-positive early-stage breast cancer in women aged 70 years or older Matthew C. WardFrank ViciniChirag Shah Clinical trial 28 May 2020 Pages: 355 - 365
Utilization patterns and temporal trends of internal mammary nodal irradiation at a tertiary cancer center Shagun MisraGrace LeeC. Anne Koch Clinical trial 30 May 2020 Pages: 367 - 379
Risk factors for skeletal-related events in patients with bone metastasis from breast cancer undergoing treatment with zoledronate Hirotaka MiyashitaChristina CruzStephen Malamud Clinical trial 30 May 2020 Pages: 381 - 388
Low-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer—results of an exploratory case–control study S. KrajnakC. SchnatzM. J. Battista Clinical trial Open access 03 June 2020 Pages: 389 - 399
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study Giuseppe BuonoAnna CrispoGrazia Arpino Clinical trial Open access 04 June 2020 Pages: 401 - 409
Radiation and/or endocrine therapy? Recurrence and survival outcomes in women over 70 with early breast cancer after breast-conserving surgery Hannah DahnDerek WilkeJean-Philippe Pignol Epidemiology 21 May 2020 Pages: 411 - 420
Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers Deborah CragunAnne WeidnerTuya Pal Epidemiology 22 May 2020 Pages: 421 - 428
Does oncoplastic surgery increase immediate (30-day) postoperative complications? An analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database Fernando A. AngaritaSergio A. AcunaTulin D. Cil Epidemiology 25 May 2020 Pages: 429 - 438
Overall health at diagnosis predicts the risk of complications within the first year after breast cancer diagnosis Cecilia T. OngYi RenRachel A. Greenup Epidemiology 28 May 2020 Pages: 439 - 449
Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study Anna H. WuChiuchen TsengDarcy Spicer Epidemiology Open access 28 May 2020 Pages: 451 - 463
Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis Blanche P. AlterAna F. Best Epidemiology 02 June 2020 Pages: 465 - 476
Stage-specific survival has improved for young breast cancer patients since 2000: but not equally Cassia Bree TrewinAnna Louise Viktoria JohanssonGiske Ursin Epidemiology Open access 03 June 2020 Pages: 477 - 489
Simple prediction model for homologous recombination deficiency in breast cancers in adolescents and young adults Tomoko WatanabeTakayuki HondaTakashi Kohno Epidemiology 03 June 2020 Pages: 491 - 502
Somatic mutations of triple-negative breast cancer: a comparison between Black and White women Angela R. OmilianLei WeiSong Yao Brief report 21 May 2020 Pages: 503 - 509
Response to the article by Dietz et al. entitled “Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID‑19 pandemic. The COVID‑19 pandemic breast cancer consortium” Peter BeitschPat WhitworthRakesh Patel Letter to the Editor 26 May 2020 Pages: 511 - 512
Reply to letters to the editor: Discordance in estrogen receptor and change of Ki67 between primary site and metastatic site of recurrent breast cancer Junichiro Watanabe Rebuttal Letter 21 May 2020 Pages: 513 - 514
